Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11517621 Treatment of severe community acquired pneumonia

Patent 11517621 was granted and assigned to Biotest AG on December, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Ulrike Wippermann0

Andrea Wartenberg-Demand0

Benjamin Daelken0

Patrick Langohr0

Date of Patent

December 6, 2022

0

Patent Application Number

171499270

Date Filed

January 15, 2021

0

Patent Primary Examiner

0

The present invention provides for a new therapeutic tools capable of treating infectious diseases, in particular, a new pharmaceutical composition comprising an IgM-enriched immunoglobulin preparation for use in the adjunctive treatment of severe Community Acquired Pneumonia (sCAP).

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11517621 Treatment of severe community acquired pneumonia

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.